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1602database, younger patients (age <40 years) were less
likely to have hypertension and were more likely to
have Marfan syndrome, bicuspid aortic valve, and
prior cardiac surgery (p < 0.05), all risk factors for
dissection (5).
On the basis of the limited data presented, it is
difﬁcult to draw the broad conclusion that pregnancy
is an independent risk factor for dissection. It would
be helpful to know more about the methods used,
including how the statistical analysis was conducted,
and to know the prevalence for dissection risk factors
aside from hypertension and Marfan syndrome.*Judith Z. Goldﬁnger, MD
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CHA2DS2-VASc Score?Oral anticoagulation therapy for stroke prevention is
the cornerstone of atrial ﬁbrillation (AF) manage-
ment. Current international guidelines focus on ac-
curate identiﬁcation of “truly low-risk” patients in
order to exclude them from such therapy, reserving
it for those with immediate or high stroke risk.
Accordingly, the CHA2DS2-VASc score has been rec-
ommended as the standard means of stroke risk
stratiﬁcation. With the exception of those with aCHA2DS2-VASc score of 0, that is an annual stroke risk
of 0.7%/year, oral anticoagulation therapy should be
considered/recommended (Class I, Level of Evidence:
A, and Class IIa, Level of Evidence: A).
In a recently published article in the Journal, Chao
et al. (1) compared the performance of the CHA2DS2-
VASc score with that of the ATRIA (Anticoagulation
and Risk Factors in Atrial Fibrillation) score in the
prediction of stroke in a large contemporary Chinese
population with AF in Taiwan. Like previous large
validation cohorts from Western Europe (2,3) and
North America (4), stroke risk in the Taiwan cohort
increased with increasing CHA2DS2-VASc score.
Nonetheless, a striking feature of the Taiwan cohort
was that although patients with a high CHA2DS2-VASc
score had a comparable stroke risk with previous
Caucasian series, the annual stroke risk in those with
a low CHA2DS2-VASc score was 2- to 3-fold higher
(Figure 1). This is consistent with our recent ﬁnding in
a hospital-based Chinese cohort in Hong Kong (5). In
addition, exploration of data from recent randomized
controlled trials of non-vitamin K oral anticoagulants
(NOACs) for stroke prevention in AF, revealed that
despite comparable CHA2DS2-VASc scores, the annual
stroke risk amongst Asian AF patients is likewise
higher, up to 2.5-fold that of comparable non-Asian
individuals prescribed the same treatment. These
ﬁndings concur with the evidence that globally,
China and other Asian countries are amongst the
countries with the highest incidence of stroke. These
data inevitably raise the possibility that ethnicity is
an important risk factor with an additive role that can
improve risk stratiﬁcation scores in AF. One simple
and straightforward way to modify the CHA2DS2-
VASc score for the Chinese population with a high
baseline stroke risk is to add one more “C” (“C” for
Chinese) to the score, i.e., C2HA2DS2-VASc score.
Although such an approach may enable recalibra-
tion of the stroke risk stratiﬁcation for Chinese AF
patients and align with data derived from previous
Caucasian series, attributing the observed difference
in stroke risk to ethnicity alone may be an over-
simpliﬁcation. This difference in stroke risk between
Chinese and previous Caucasian cohorts, as stratiﬁed
by the CHA2DS2-VASc score, may indicate a missing
component risk factor in the score that contributes to
stroke in Chinese or Asians. Examples may include
factors such as age 55 to 64 years, undiagnosed and/or
suboptimally treated hypertension, and hyperthy-
roidism. Another plausible explanation for the high
stroke risk in Chinese AF patients is related to the
high prevalence of noncardioembolic stroke in Chi-
nese. For instance, intracranial atherosclerosis ac-
counts for one-third to one-half of strokes and 45% of
FIGURE 1 The Annual Stroke Risk Stratiﬁed With CHA2DS2-VASc Scores
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The annual stroke risk is stratiﬁed with CHA2DS2-VASc scores from different epidemiological series: United States (4), Sweden (2), Denmark (3),
Taiwan (1), and Hong Kong (5).
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1603transient ischemic strokes in Chinese. A similar
observation has been made in other Asian countries.
Unfortunately, little is reported about the subtypes of
stroke in most registries or even in randomized
controlled trials. Notwithstanding, the burning
question remains whether clinicians should initiate
long-term anticoagulation therapy in Chinese pa-
tients with AF and a CHA2DS2-VASc score of 0. It is
very tempting to do so, given the excellent safety
proﬁle of NOACs that has resulted in a lowering of the
threshold for initiating NOAC treatment to an annual
stroke risk of 1%/year. Nonetheless, it lacks support
from randomized placebo-controlled trials, the gold
standard to demonstrate treatment effects, specif-
ically targeted at this presumably “low-risk” popula-
tion. Further research is vital to determine the risk of
cardioembolic stroke as well as other subtypes of
stroke amongst Chinese patients with AF and to
develop new stroke risk models that accurately
stratify such risks.*Chung-Wah Siu, MD
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1401–8.REPLY: One More “C” for
CHA2DS2-VASc ScoreWe thank Dr. Siu for his comments regarding our
recently published paper (1) about the usefulness of
the CHA2DS2-VASc score for reﬁning stroke risk
stratiﬁcation among patients with atrial ﬁbrillation
(AF) having an ATRIA (Anticoagulation and Risk
Factors in Atrial Fibrillation) score of 0 to 5. We agree
that the risk of ischemic stroke for Chinese AF pa-
tients with a CHA2DS2-VASc score of 0 is higher than
that of Caucasians. However, it does not mean that
non-vitamin K antagonist oral anticoagulants
(NOACs) should be routinely prescribed for these
